Clinical characteristics of Pneumocystis pneumonia in non-HIV patients and prognostic factors including microbiological genotypes

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Matsumura, Yasufumi ^a   Shindo, Yuichiro ^b   Iinuma, Yoshitsugu ^c   Yamamoto, Masaki ^a   Shirano, Michinori ^d   Matsushima, Aki ^a   Nagao, Miki ^a   Ito, Yutaka ^a   Takakura, Shunji ^a   Hasegawa, Yoshinori ^b   Ichiyama, Satoshi ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KANAZAWA MEDICAL UNIVERSITY   (Japan)

^d OSAKA CITY GENERAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; BETA 1,3 GLUCAN; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOSPORIN; DIHYDROPTEROATE SYNTHASE; ETANERCEPT; INFLIXIMAB; INTERNAL TRANSCRIBED SPACER; METHOTREXATE; METHYLPREDNISOLONE; PENTAMIDINE; PREDNISOLONE; PREDNISONE; RIBOSOME RNA; TACROLIMUS; BACTERIAL DNA; BETA GLUCAN; MITOCHONDRIAL DNA;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ANTIBIOTIC RESISTANCE; ARTICLE; ARTIFICIAL VENTILATION; BLOOD LEVEL; CELL NUCLEUS; CLINICAL FEATURE; CYTOMEGALOVIRUS INFECTION; FEMALE; GENOTYPE; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATORY DISEASE; LUNG ASPERGILLOSIS; MAJOR CLINICAL STUDY; MALE; MITOCHONDRION; MORTALITY; OPERON; ORGAN TRANSPLANTATION; PNEUMOCYSTIS PNEUMONIA; PROGNOSIS; RETROSPECTIVE STUDY; SOLID TUMOR; SURVIVOR; CLINICAL TRIAL; GENETICS; JAPAN; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS JIROVECI;

ADULT; AGED; AGED, 80 AND OVER; BETA-GLUCANS; DNA, BACTERIAL; DNA, MITOCHONDRIAL; FEMALE; GENOTYPE; HIV INFECTIONS; HUMANS; JAPAN; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; PROGNOSIS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 79953088705     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-76     Document Type: Article

References (48)

1. Mansharamani N, Garland R, Delaney D, Koziel H. Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995: comparison of HIV-associated cases to other immunocompromised states. Chest 2000, 118:704-711.
2. Kelley C, Checkley W, Mannino D, Franco-Paredes C, Del Rio C, Holguin F. Trends in hospitalizations for AIDS-associated Pneumocystis jirovecii Pneumonia in the United States (1986 to 2005). Chest 2009, 136:190-197.
3. Limper A, Offord K, Smith T, Martin W. Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis 1989, 140:1204-1209.
4. Azoulay E, Bergeron A, Chevret S, Bele N, Schlemmer B, Menotti J. Polymerase chain reaction for diagnosing pneumocystis pneumonia in non-HIV immunocompromised patients with pulmonary infiltrates. Chest 2009, 135:655-661.
5. Procop GW, Haddad S, Quinn J, Wilson ML, Henshaw NG, Reller LB, Artymyshyn RL, Katanik MT, Weinstein MP. Detection of Pneumocystis jiroveci in respiratory specimens by four staining methods. J Clin Microbiol 2004, 42:3333-3335.
6. Krajicek BJ, Thomas CF, Limper AH. Pneumocystis pneumonia: current concepts in pathogenesis, diagnosis, and treatment. Clin Chest Med 2009, 30:265-278.
7. Thomas CJ, Limper A. Pneumocystis pneumonia. N Engl J Med 2004, 350:2487-2498.
8. Morris A, Wei K, Afshar K, Huang L. Epidemiology and clinical significance of pneumocystis colonization. J Infect Dis 2008, 197:10-17.
9. Jiancheng W, Minjun H, Yi-jun A, Lan S, Zengzhu G, Jianrong S, Xixiong K. Screening Pneumocystis carinii pneumonia in non-HIV-infected immunocompromised patients using polymerase chain reaction. Diagn Microbiol Infect Dis 2009, 64:396-401.
10. Watanabe T, Yasuoka A, Tanuma J, Yazaki H, Honda H, Tsukada K, Honda M, Gatanaga H, Teruya K, Kikuchi Y, et al. Serum (1→3)-β-D-glucan as a noninvasive adjunct marker for the diagnosis of Pneumocystis pneumonia in patients with AIDS. Clin Infect Dis 2009, 49:1128-1131.
11. Tasaka S, Hasegawa N, Kobayashi S, Yamada W, Nishimura T, Takeuchi T, Ishizaka A. Serum indicators for the diagnosis of pneumocystis pneumonia. Chest 2007, 131:1173-1180.
12. Shimizu Y, Sunaga N, Dobashi K, Fueki M, Fueki N, Makino S, Mori M. Serum markers in interstitial pneumonia with and without Pneumocystis jirovecii colonization: a prospective study. BMC Infect Dis 2009, 9:47.
13. Beard C, Roux P, Nevez G, Hauser P, Kovacs J, Unnasch T, Lundgren B. Strain typing methods and molecular epidemiology of Pneumocystis pneumonia. Emerg Infect Dis 2004, 10:1729-1735.
14. Miller R, Wakefield A. Pneumocystis carinii genotypes and severity of pneumonia. Lancet 1999, 353:2039-2040.
15. Helweg-Larsen J, Benfield T, Eugen-Olsen J, Lundgren J, Lundgren B. Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia. Lancet 1999, 354:1347-1351.
16. Alvarez-Martínez M, Moreno A, Miró J, Valls M, Rivas P, de Lazzari E, Sued O, Benito N, Domingo P, Ribera E, et al. Pneumocystis jirovecii pneumonia in Spanish HIV-infected patients in the combined antiretroviral therapy era: prevalence of dihydropteroate synthase mutations and prognostic factors of mortality. Diagn Microbiol Infect Dis 2008, 62:34-43.
17. Vincent J, de Mendonça A, Cantraine F, Moreno R, Takala J, Suter P, Sprung C, Colardyn F, Blecher S. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med 1998, 26:1793-1800.
18. De Pauw B, Walsh T, Donnelly J, Stevens D, Edwards J, Calandra T, Pappas P, Maertens J, Lortholary O, Kauffman C, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008, 46:1813-1821.
19. Wakefield A, Pixley F, Banerji S, Sinclair K, Miller R, Moxon E, Hopkin J. Detection of Pneumocystis carinii with DNA amplification. Lancet 1990, 336:451-453.
20. Esteves F, Montes-Cano M, de la Horra C, Costa M, Calderón E, Antunes F, Matos O. Pneumocystis jirovecii multilocus genotyping profiles in patients from Portugal and Spain. Clin Microbiol Infect 2008, 14:356-362.
21. Beser J, Hagblom P, Fernandez V. Frequent in vitro recombination in internal transcribed spacers 1 and 2 during genotyping of Pneumocystis jirovecii. J Clin Microbiol 2007, 45:881-886.
22. Hosoya N, Takahashi T, Wada M, Endo T, Nakamura T, Sakashita H, Kimura K, Ohnishi K, Nakamura Y, Mizuochi T, et al. Genotyping of Pneumocystis carinii f. sp. hominis isolates in Japan based on nucleotide sequence variations in internal transcribed spacer regions of rRNA genes. Microbiol Immunol 2000, 44:591-596.
23. Totet A, Pautard J, Raccurt C, Roux P, Nevez G. Genotypes at the internal transcribed spacers of the nuclear rRNA operon of Pneumocystis jiroveci in nonimmunosuppressed infants without severe pneumonia. J Clin Microbiol 2003, 41:1173-1180.
24. Lee C, Helweg-Larsen J, Tang X, Jin S, Li B, Bartlett M, Lu J, Lundgren B, Lundgren J, Olsson M, et al. Update on Pneumocystis carinii f. sp. hominis typing based on nucleotide sequence variations in internal transcribed spacer regions of rRNA genes. J Clin Microbiol 1998, 36:734-741.
25. Siripattanapipong S, Worapong J, Mungthin M, Leelayoova S, Tan-ariya P. Genotypic study of Pneumocystis jirovecii in human immunodeficiency virus-positive patients in Thailand. J Clin Microbiol 2005, 43:2104-2110.
26. Kovacs JA, Hiemenz JW, Macher AM, Stover D, Murray HW, Shelhamer J, Lane HC, Urmacher C, Honig C, Longo DL. Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med 1984, 100:663-671.
27. Helweg-Larsen J, Jensen J, Benfield T, Svendsen U, Lundgren J, Lundgren B. Diagnostic use of PCR for detection of Pneumocystis carinii in oral wash samples. J Clin Microbiol 1998, 36:2068-2072.
28. Yale S, Limper A. Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy. Mayo Clin Proc 1996, 71:5-13.
29. Roblot F, Godet C, Le Moal G, Garo B, Faouzi Souala M, Dary M, De Gentile L, Gandji J, Guimard Y, Lacroix C, et al. Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIV-negative patients. Eur J Clin Microbiol Infect Dis 2002, 21:523-531.
30. Komano Y, Harigai M, Koike R, Sugiyama H, Ogawa J, Saito K, Sekiguchi N, Inoo M, Onishi I, Ohashi H, et al. Pneumocystis jiroveci pneumonia in patients with rheumatoid arthritis treated with infliximab: a retrospective review and case-control study of 21 patients. Arthritis Rheum 2009, 61:305-312.
31. Rodriguez M, Fishman J. Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients. Clin Microbiol Rev 2004, 17:770-782.
32. Iikuni N, Kitahama M, Ohta S, Okamoto H, Kamatani N, Nishinarita M. Evaluation of Pneumocystis pneumonia infection risk factors in patients with connective tissue disease. Mod Rheumatol 2006, 16:282-288.
33. Saito K, Nakayamada S, Nakano K, Tokunaga M, Tsujimura S, Nakatsuka K, Adachi T, Tanaka Y. Detection of Pneumocystis carinii by DNA amplification in patients with connective tissue diseases: re-evaluation of clinical features of P. carinii pneumonia in rheumatic diseases. Rheumatology (Oxford) 2004, 43:479-485.
34. Held J, Koch M, Reischl U, Danner T, Serr A. Serum (1→3)-β-D-glucan measurement as early indicator for Pneumocystis jirovecii pneumonia and evaluation of its prognostic value. Clin Microbiol Infect
35. de Boer MG, Gelinck LB, van Zelst BD, van de Sande WW, Willems LN, van Dissel JT, de Jonge R, Kroon FP. β-D-glucan and S-adenosylmethionine serum levels for the diagnosis of Pneumocystis pneumonia in HIV-negative Patients: A prospective study. J Infect 2010, 62:93-100.
36. Segal BH, Walsh TJ. Current approaches to diagnosis and treatment of invasive aspergillosis. Am J Respir Crit Care Med 2006, 173:707-717.
37. Aoki Y, Iwamoto M, Kamata Y, Nagashima T, Yoshio T, Okazaki H, Minota S. Prognostic indicators related to death in patients with Pneumocystis pneumonia associated with collagen vascular diseases. Rheumatol Int 2009, 29:1327-1330.
38. Takahashi T, Hosoya N, Endo T, Nakamura T, Sakashita H, Kimura K, Ohnishi K, Nakamura Y, Iwamoto A. Relationship between mutations in dihydropteroate synthase of Pneumocystis carinii f. sp. hominis isolates in Japan and resistance to sulfonamide therapy. J Clin Microbiol 2000, 38:3161-3164.
39. Kazanjian P, Armstrong W, Hossler P, Burman W, Richardson J, Lee C, Crane L, Katz J, Meshnick S. Pneumocystis carinii mutations are associated with duration of sulfa or sulfone prophylaxis exposure in AIDS patients. J Infect Dis 2000, 182:551-557.
40. van Hal S, Gilgado F, Doyle T, Barratt J, Stark D, Meyer W, Harkness J. Clinical significance and phylogenetic relationship of novel Australian Pneumocystis jirovecii genotypes. J Clin Microbiol 2009, 47:1818-1823.
41. Olsson M, Eriksson B, Elvin K, Strandberg M, Wahlgren M. Genotypes of clustered cases of Pneumocystis carinii pneumonia. Scand J Infect Dis 2001, 33:285-289.
42. Montes-Cano M, de la Horra C, Martin-Juan J, Varela J, Torronteras R, Respaldiza N, Medrano F, Calderón E. Pneumocystis jiroveci genotypes in the Spanish population. Clin Infect Dis 2004, 39:123-128.
43. Miller RF, Lindley AR, Copas A, Ambrose HE, Davies RJ, Wakefield AE. Genotypic variation in Pneumocystis jirovecii isolates in Britain. Thorax 2005, 60:679-682.
44. Beard CB, Carter JL, Keely SP, Huang L, Pieniazek NJ, Moura IN, Roberts JM, Hightower AW, Bens MS, Freeman AR, et al. Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission. Emerg Infect Dis 2000, 6:265-272.
45. Beard CB, Fox MR, Lawrence GG, Guarner J, Hanzlick RL, Huang L, del Rio C, Rimland D, Duchin JS, Colley DG. Genetic differences in Pneumocystis isolates recovered from immunocompetent infants and from adults with AIDS: Epidemiological Implications. J Infect Dis 2005, 192:1815-1818.
46. Valerio A, Tronconi E, Mazza F, Fantoni G, Atzori C, Tartarone F, Duca P, Cargnel A. Genotyping of Pneumocystis jiroveci pneumonia in Italian AIDS patients. Clinical outcome is influenced by dihydropteroate synthase and not by internal transcribed spacer genotype. J Acquir Immune Defic Syndr 2007, 45:521-528.
47. Helweg-Larsen J, Tsolaki A, Miller R, Lundgren B, Wakefield A. Clusters of Pneumocystis carinii pneumonia: analysis of person-to-person transmission by genotyping. QJM 1998, 91:813-820.
48. Robberts FJ, Liebowitz LD, Chalkley LJ. Genotyping and coalescent phylogenetic analysis of Pneumocystis jiroveci from South Africa. J Clin Microbiol 2004, 42:1505-1510.